Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $20.4200 (1.85%) ($20.4200 - $20.4200) on Fri. Jan. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.21% (three month average) | RSI | 39 | Latest Price | $20.4200(1.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.8% a day on average for past five trading days. | Weekly Trend | ATRA declines -6.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.105% in a week (0% probabilities). VIXM(-34%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.105% (StdDev 4.21%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $7.08(-65.33%) | Resistance Level | $21.42 | 5 Day Moving Average | $19.63(4.02%) | 10 Day Moving Average | $20.16(1.29%) | 20 Day Moving Average | $21.42(-4.67%) | To recent high | -22.4% | To recent low | 61% | Market Cap | $1.517b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |